Clinical Trial Update: A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine [Phase 2]

View source ↗

Summary

A Phase 2 crossover trial evaluating the combination of QAV680 and cetirizine for allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Cetirizine (cetirizine)
• QAV680

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED